The Patent Finder

Cytrx Corporation

Also on record
Records under this name other than the patents Cytrx Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Cytrx Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,384,104Delivery systems for controlled drug release
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,497,417Delivery systems for controlled drug release
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,377,473Albumin-Binding Prodrugs of Auristatin E Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,572,373Maytansinoid-Based Drug Delivery Systems
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,962,604Use of a Hydroximic Acid Halide Derivative in the Treatment of Neurodegenerative Diseases
Formerly held
Lapsed on the fee record
Ended Feb 24, 2023 · Medium confidence
Lapsed on the fee recordEnded Feb 24, 2023Medium confidence
US 7,691,849Carboxamidine derivatives and their use in the treatment of vascular diseases
Formerly held
Lapsed on the fee record
Ended Apr 6, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 6, 2022USPTO record
US 7,126,002Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
Formerly held
Term ended
Term ended Oct 14, 2021 · USPTO record
Term endedTerm ended Oct 14, 2021USPTO record
US 7,550,457Pharmaceutically effective compounds
Formerly held
Lapsed on the fee record
Ended Jun 23, 2021 · USPTO record
Lapsed on the fee recordEnded Jun 23, 2021USPTO record
US 6,384,029Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseases
Formerly held
Term ended
Term ended May 15, 2021 · USPTO record
Term endedTerm ended May 15, 2021USPTO record
US 7,384,936Carboxamidine derivatives and their use in the treatment of vascular diseases
Formerly held
Lapsed on the fee record
Ended Jun 10, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 10, 2020USPTO record
10 of 40 patents shown.
Pro members see all 40.
Pro members: see all 40 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited